Dr. Ricklie A. Julian
Claim this profileBanner University Medical Center - Tucson
Studies Squamous Cell Carcinoma
Studies Skin Cancer
8 reported clinical trials
16 drugs studied
Area of expertise
1Squamous Cell Carcinoma
p16 negative
Stage III
Stage IV
2Skin Cancer
Stage III
p16 positive
p16 negative
Affiliated Hospitals
Clinical Trials Ricklie A. Julian is currently running
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
Abemaciclib
for Head and Neck Cancer
This is a Phase II single-arm window trial to assess the clinical and biological effects of neoadjuvant abemaciclib in patients with HPV-negative head and neck squamous cell carcinoma (HNSCC).
Recruiting1 award Phase 213 criteria
More about Ricklie A. Julian
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Ricklie A. Julian has experience with
- Cisplatin
- Atezolizumab
- Intensity-Modulated Radiation Therapy
- Cetuximab
- Abemaciclib
- Nivolumab
Breakdown of trials Ricklie A. Julian has run
Squamous Cell Carcinoma
Skin Cancer
Throat Cancer
Lung Cancer
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ricklie A. Julian specialize in?
Ricklie A. Julian focuses on Squamous Cell Carcinoma and Skin Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved p16 negative patients, or patients who are Stage III.
Is Ricklie A. Julian currently recruiting for clinical trials?
Yes, Ricklie A. Julian is currently recruiting for 4 clinical trials in Tucson Arizona. If you're interested in participating, you should apply.
Are there any treatments that Ricklie A. Julian has studied deeply?
Yes, Ricklie A. Julian has studied treatments such as Cisplatin, Atezolizumab, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Ricklie A. Julian?
Apply for one of the trials that Ricklie A. Julian is conducting.
What is the office address of Ricklie A. Julian?
The office of Ricklie A. Julian is located at: Banner University Medical Center - Tucson, Tucson, Arizona 85719 United States. This is the address for their practice at the Banner University Medical Center - Tucson.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.